Malignant Cells, Directors of the Malignant Process: Role of Transforming Growth Factor-beta

[1]  R. Jirtle,et al.  Liver tumor promotion: Effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-β1 expression , 1991, Digestive Diseases and Sciences.

[2]  Beverly A. Teicher,et al.  A systems approach to cancer therapy , 1996, Cancer and Metastasis Reviews.

[3]  M. Steiner.  Transforming growth factor-β and prostate cancer , 1995, World Journal of Urology.

[4]  R. W. Padgett.  TGFβ Signaling Pathways and Human Diseases , 2004, Cancer and Metastasis Reviews.

[5]  U. Studer,et al.  Differential expression of transforming growth factor-β1 and β3 as well as C-FOS mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer , 2004, World Journal of Urology.

[6]  B. Teicher,et al.  Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumors , 2004, Cancer Chemotherapy and Pharmacology.

[7]  Z. Tulassay,et al.  [Neuroendocrine tumors of the digestive system]. , 2002, Orvosi hetilap.

[8]  J. Letterio.  Cancer Models: Manipulating the Transforming Growth Factor-β Pathway in Mice , 2001 .

[9]  E. Ziv,et al.  Association between the T29-->C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures. , 2001, JAMA.

[10]  C. Muro-Cacho,et al.  Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  T. Tsushima,et al.  Transforming growth factor‐β1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma , 2001 .

[12]  A. Tumber,et al.  Human breast‐cancer cells stimulate the fusion, migration and resorptive activity of osteoclasts in bone explants , 2001, International journal of cancer.

[13]  F. Ando,et al.  Transforming Growth Factor-β1 Gene Polymorphism and Bone Mineral Density , 2001 .

[14]  R. Wieser.  The transforming growth factor-β signaling pathway in tumorigenesis , 2001 .

[15]  M. Hendrix,et al.  Invasion and metastasis of a mammary tumor involves TGF‐β signaling , 2001 .

[16]  Fumiko Itoh,et al.  Signaling of transforming growth factor‐β family members through Smad proteins , 2000 .

[17]  K. Krieglstein,et al.  Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. , 2000, European journal of biochemistry.

[18]  F. Cavalli,et al.  Identifying breast cancer patients at high risk for bone metastases. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  R. Weinberg,et al.  Disruption of TGF-β growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization , 2000, Oncogene.

[20]  N. Sibinga,et al.  Transforming Growth Factor-β1 Inhibition of Macrophage Activation Is Mediated via Smad3* , 2000, The Journal of Biological Chemistry.

[21]  M. Jakobsen,et al.  Human breast cancer cells induce angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis , 2000, Journal of Cancer Research and Clinical Oncology.

[22]  Ester Piek,et al.  Role of Transforming Growth Factor-β Signaling in Cancer , 2000 .

[23]  S. Rhodes,et al.  Identification of transforming growth factor‐β1‐binding protein overexpression in carmustine‐resistant glioma cells by MRNA differential display , 2000 .

[24]  W. Karpus,et al.  Down-regulation of TGF- β 1 production restores immunogenicity in prostate cancer cells , 2000, British Journal of Cancer.

[25]  R. Hamdy,et al.  Mechanism of transforming growth factor-beta1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells. , 2000, Biochimica et biophysica acta.

[26]  M. Bouché,et al.  TGF‐β autocrine loop regulates cell growth and myogenic differentiation in human rhabdomyosarcoma cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  H. Levitsky.  Augmentation of host immune responses to cancer: overcoming the barrier of tumor antigen-specific T-cell tolerance. , 2000, Cancer journal.

[28]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[29]  I. Fidler.  Angiogenesis and cancer metastasis. , 2000, Cancer journal.

[30]  B. Teicher,et al.  Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo. , 2000, International journal of oncology.

[31]  R Weissleder,et al.  Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin. , 2000, European journal of cancer.

[32]  K. Matsuzaki,et al.  Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma. , 2000, Cancer research.

[33]  J. G. Park,et al.  Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  A. Loercher,et al.  In vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin. , 1999, Cancer research.

[35]  C. Heldin,et al.  Specificity, diversity, and regulation in TGF‐β superfamily signaling , 1999 .

[36]  M. Reiss.  TGF- and cancer , 1999 .

[37]  H. Ostrer,et al.  TβR-I(6A) Is a Candidate Tumor Susceptibility Allele , 1999 .

[38]  E. Bluman,et al.  Regulation of transforming growth factor beta1 by radiation in cells of two human breast cancer cell lines. , 1999, Radiation research.

[39]  R. Clough,et al.  Plasma transforming growth factor‐β1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma , 1999, Cancer.

[40]  V. Koteliansky,et al.  In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Korc,et al.  TGF‐β‐1 up‐regulates cyclin D1 expression in colo‐357 cells, whereas suppression of cyclin d1 levels is associated with down‐regulation of the type I TGF‐β receptor , 1999 .

[42]  H. Klingler,et al.  Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGFβ) , 1999, The Prostate.

[43]  S. Iyer,et al.  Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. , 1999, The Journal of pharmacology and experimental therapeutics.

[44]  L. Sun,et al.  A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. , 1999, Cancer research.

[45]  L. Wakefield,et al.  Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells. , 1999, Cancer research.

[46]  E. Gilboa.  How tumors escape immune destruction and what we can do about it , 1999, Cancer Immunology, Immunotherapy.

[47]  M. Whitman,et al.  The role of transcription factors involved in TGFbeta superfamily signaling during development. , 1999, Cellular and molecular biology.

[48]  M. Cronauer,et al.  Transforming growth factor‐β in benign and malignant prostate , 1999 .

[49]  R Wieser,et al.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.

[50]  L. Gold.  The role for transforming growth factor-beta (TGF-beta) in human cancer. , 1999, Critical reviews in oncogenesis.

[51]  Anita B. Roberts,et al.  REGULATION OF IMMUNE RESPONSES BY TGF-β* , 1998 .

[52]  J. Letterio,et al.  TGF-β Knockout and Dominant-Negative Receptor Transgenic Mice , 1998, Mineral and Electrolyte Metabolism.

[53]  J. Letterio,et al.  TGF-beta knockout and dominant-negative receptor transgenic mice. , 1998, Mineral and electrolyte metabolism.

[54]  A. Roberts,et al.  Regulation of immune responses by TGF-beta. , 1998, Annual review of immunology.

[55]  R. Herbst,et al.  Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin. , 1997, In vivo.

[56]  Luzhe Sun,et al.  Expression of Transforming Growth Factor β Type III Receptor Suppresses Tumorigenicity of Human Breast Cancer MDA-MB-231 Cells* , 1997, The Journal of Biological Chemistry.

[57]  P. Delmas,et al.  Decorin inhibits cell attachment to thrombospondin‐1 by binding to a KKTR‐dependent cell adhesive site present within the N‐terminal domain of thrombospondin‐1 , 1997, Journal of cellular biochemistry.

[58]  A. Roberts,et al.  TGF-β: A Critical Modulator of Immune Cell Function☆ , 1997 .

[59]  D. Roop,et al.  A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice. , 1997, The Journal of clinical investigation.

[60]  T. Gress,et al.  Extracellular matrix is reduced by inhibition of transforming growth factor beta1 in pancreatitis in the rat. , 1997, Gastroenterology.

[61]  S. Thorgeirsson,et al.  Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice. , 1997, Cancer research.

[62]  N. Kyprianou,et al.  Down‐regulation of protein and mRNA expression for transforming growth factor‐β (TGF‐β1) type I and type II receptors in human prostate cancer , 1997 .

[63]  H. Mannherz,et al.  TGF-β-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes , 1997 .

[64]  S. Wojtowicz-Praga.  Reversal of Tumor-Induced Immunosuppression: A New Approach to Cancer Therapy , 1997, Journal of immunotherapy.

[65]  C. Gerharz,et al.  Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[66]  Z. Toossi,et al.  In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[67]  E. Barrack.  TGFβ in prostate cancer: A growth inhibitor that can enhance tumorigenicity , 1997 .

[68]  Y. Maehara,et al.  Reversal of in vivo drug resistance by the transforming growth factor‐β inhibitor decorin , 1997, International journal of cancer.

[69]  Y. Kakeji,et al.  Dynamics of tumor oxygenation, CD31 staining and transforming growth factor-beta levels after treatment with radiation or cyclophosphamide in the rat 13762 mammary carcinoma. , 1997, International journal of radiation oncology, biology, physics.

[70]  M. Choudhry,et al.  Transforming growth factor‐β negatively modulates T‐cell responses in sepsis , 1997 .

[71]  J. Grande.  Role of Transforming Growth Factor-β in Tissue Injury and Repair , 1997 .

[72]  E. Hersh,et al.  Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells. , 1997, Cancer gene therapy.

[73]  J. Tsai,et al.  Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma. , 1997, British Journal of Cancer.

[74]  D. Danielpour,et al.  Regulation of Apoptosis Induced by Transforming Growth Factor-β1 in Nontumorigenic and Tumorigenic Rat Prostatic Epithelial Cell Lines , 1996 .

[75]  J. Grande,et al.  Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer : Paracrine regulation by carcinoma cell-derived members of the transforming growth factor β family , 1996 .

[76]  M. Monden,et al.  Mutations of the transforming growth factor β type II receptor gene and microsatellite instability in gastric cancer , 1996, International journal of cancer.

[77]  Allan Balmain,et al.  TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice , 1996, Cell.

[78]  K. Miyazono,et al.  Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[79]  J. Bartlett,et al.  Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy. , 1996, British Journal of Cancer.

[80]  S. Saga,et al.  Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. , 1996, Cancer research.

[81]  G. Viale,et al.  Transforming growth factor beta 1 (TGF-beta 1) expression in proliferating thyroid disease. , 1996, International journal of oncology.

[82]  M. Granick,et al.  Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer. , 1996, The Journal of surgical research.

[83]  L. Seymour,et al.  Comparison between immunocytochemical and polymerase chain reaction techniques for detection of oestrogen receptor and transforming growth factor beta in breast cancer. , 1996, British Journal of Cancer.

[84]  H. Poulsen,et al.  Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines. , 1996, British Journal of Cancer.

[85]  P. Scardino,et al.  Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[86]  J. Wright,et al.  Growth factors in mechanisms of malignancy: roles for TGF-beta and FGF. , 1996, Histology and histopathology.

[87]  K. Miyazono,et al.  Distribution of Transforming Growth Factor‐β and Its Receptors in Gastric Carcinoma Tissue , 1996, Japanese journal of cancer research : Gann.

[88]  Chung Lee,et al.  Modulation of Sensitivity to Transforming Growth Factor-β1 (TGF-β1) and the Level of Type II TGF-β Receptor in LNCaP Cells by Dihydrotestosterone , 1996 .

[89]  Chung Lee,et al.  Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells , 1996 .

[90]  B. Teicher,et al.  Transforming growth factor-β in in vivo resistance , 1996, Cancer Chemotherapy and Pharmacology.

[91]  Kathleen R. Cho,et al.  A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. , 1995, Cancer research.

[92]  M. Ewen,et al.  Trypanosome invasion of mammalian cells requires activation of the TGF-β signaling pathway , 1995 .

[93]  M. Granick,et al.  Thrombospondin and transforming growth factor‐beta 1 increase expression of urokinase‐type plasminogen activator and plasminogen activator inhibitor‐1 in human MDA‐MB‐231 breast cancer cells , 1995, Cancer.

[94]  M. Reiss,et al.  Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells. , 1995, Cancer research.

[95]  J. Coggle,et al.  Expression of transforming growth factor-beta 1 in mouse skin during the acute phase of radiation damage. , 1995, International journal of radiation biology.

[96]  K. Miyazono,et al.  Enhanced expression of transforming growth factor‐β and its type‐I and type‐II receptors in human glioblastoma , 1995, International journal of cancer.

[97]  C. Boland,et al.  Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. , 1995, Journal of the National Cancer Institute.

[98]  K. Osteen,et al.  Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[99]  M. Ewen,et al.  Trypanosome invasion of mammalian cells requires activation of the TGFβ signaling pathway , 1995, Cell.

[100]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[101]  Jim A. Wright,et al.  Drug Resistance and Gene Amplification Potential Regulated by Transforming Growth Factor β1 Gene Expression , 1995 .

[102]  V. Baldin,et al.  Effects of TGF‐β1 (transforming growth factor‐β1) on the cell cycle regulation of human breast adenocarcinoma (MCF‐7) cells , 1995 .

[103]  M. Sporn,et al.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[104]  P. Bedossa,et al.  Transforming growth factor—beta 1 (TGF‐β1) and TGF‐β1 receptors in normal, cirrhotic, and neoplastic human livers , 1995, Hepatology.

[105]  S. Kar,et al.  Differentially expressed genes in TGF-β1 sensitive and resistant human hepatoma cells , 1995 .

[106]  Y. Matsuzawa,et al.  Positive correlation of plasma transforming growth factor-beta 1 levels with tumor vascularity in hepatocellular carcinoma. , 1995, Cancer letters.

[107]  栢木 善朗.  Suppression of antioxidative enzyme expression by transforming growth factor-β1 in rat hepatocytes , 1995 .

[108]  M. Sporn,et al.  Transforming Growth Factor-β1 Circulates in Normal Human Plasma and is Unchanged in Advanced Metastatic Breast Cancer , 1995 .

[109]  R. Lupu,et al.  Correlation of TGF-beta 1 expression with medroxyprogesterone acetate responsiveness in mouse mammary adenocarcinomas. , 1995, Cancer investigation.

[110]  J. Eshleman,et al.  Microsatellite instability in inherited and sporadic neoplasms. , 1995, Current opinion in oncology.

[111]  B. Lieubeau,et al.  The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development. , 1994, Cancer research.

[112]  L. Corcos,et al.  Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture. , 1994, Molecular pharmacology.

[113]  B. Katzenellenbogen,et al.  Alterations in Transforming Growth Factor-α and -β Production and Cell Responsiveness during the Progression of MCF-7 Human Breast Cancer Cells to Estrogen-Autonomous Growth , 1994 .

[114]  M. Steiner,et al.  Expression of transforming growth factor-beta 1 in prostate cancer. , 1994, Endocrinology.

[115]  C. Garbe,et al.  Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro. , 1994, Anticancer research.

[116]  H. Maeda,et al.  Improvement of Macrophage Dysfunction by Administration of Anti‐transforming Growth Factor‐β Antibody in EL4‐bearing Hosts , 1994, Japanese journal of cancer research : Gann.

[117]  J. Willson,et al.  Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells , 1994 .

[118]  M. Boulton,et al.  Oxygen regulation of TGF-beta 1 mRNA in human hepatoma (Hep G2) cells. , 1994, Biochemistry and molecular biology international.

[119]  M. Granick,et al.  Thrombospondin (TSP) and transforming growth factor beta 1 (TGF-beta) promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 (PAI-1) production and stimulate tumor cell attachment in vitro. , 1994, Biochemical and biophysical research communications.

[120]  G. Pilkington,et al.  Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. , 1994, British Journal of Cancer.

[121]  Y. Matsuzawa,et al.  Suppression of antioxidative enzyme expression by transforming growth factor-beta 1 in rat hepatocytes. , 1994, The Journal of biological chemistry.

[122]  J. Bartlett,et al.  Expression of transforming growth factor beta mRNA isoforms in human breast cancer. , 1994, British Journal of Cancer.

[123]  R. Walker,et al.  Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. , 1994, British Journal of Cancer.

[124]  Y. Matsuzawa,et al.  Plasma transforming growth factor‐β1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases , 1994, Cancer.

[125]  R. Maciunas,et al.  TGF beta 1 and TGF beta 2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: evidence in support of an autocrine hypothesis. , 1994, Human pathology.

[126]  M. Korc,et al.  Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. , 1994, Cancer research.

[127]  R. Takimoto,et al.  Transforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue. , 1994, British Journal of Cancer.

[128]  T. Fujiwara,et al.  Retroviral‐mediated transduction of p53 gene increases TGF‐β expression in a human glioblastoma cell line , 1994 .

[129]  L. Myeroff,et al.  A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene. , 1994, The Journal of clinical investigation.

[130]  S. Winawer,et al.  Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[131]  R. Eckert,et al.  Transforming Growth Factor β1 Regulation of Metalloproteinase Production in Cultured Human Cervical Epithelial Cells , 1994 .

[132]  J. Bartlett,et al.  Transforming growth-factor-Beta (tgf-Beta) messenger-RNA expression and growth-control in human lung squamous carcinoma cell-lines. , 1994, International journal of oncology.

[133]  P. Nowell,et al.  Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. , 1994, Cancer research.

[134]  M. Sporn,et al.  Induction of transforming growth factor beta in hormonally treated human prostate cancer. , 1994, British Journal of Cancer.

[135]  馬原 克夫.  Transforming growth factor-β1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue , 1994 .

[136]  Luzhe Sun,et al.  Growth factor balance and tumor progression. , 1994, Current opinion in oncology.

[137]  T. Powles,et al.  The effect of endocrine therapy on the levels of oestrogen and progesterone receptor and transforming growth factor-beta 1 in metastatic human breast cancer: an immunocytochemical study. , 1994, European journal of cancer.

[138]  M. Anscher,et al.  Changes in plasma TGFβ levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis , 1993 .

[139]  Mahlon D. Johnson,et al.  Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression. , 1993, The Journal of clinical investigation.

[140]  M. Anscher,et al.  Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer , 1993 .

[141]  A. Roberts,et al.  Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[142]  B. Teicher,et al.  Acquired multicellular-mediated resistance to alkylating agents in cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[143]  H. Moses,et al.  Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[144]  R. Kerbel,et al.  Development of resistance mechanisms to the growth‐inhibitory effects of transforming growth factor-β during tumor progression , 1993, Current opinion in oncology.

[145]  C. Arteaga,et al.  Evidence for a positive role of transforming growth factor‐β in human breast cancer cell tumorigenesis , 1993, Journal of cellular biochemistry. Supplement.

[146]  S. Reed,et al.  Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. , 1992, Science.

[147]  N. Chegini,et al.  Immunocytochemical localization of transforming growth factors (TGFs) TGF-alpha and TGF-beta in human ovarian tissues. , 1992, The Journal of clinical endocrinology and metabolism.

[148]  S. Schultz-Cherry,et al.  Transforming growth factor-beta complexes with thrombospondin. , 1992, Molecular biology of the cell.

[149]  M. Steiner,et al.  Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro. , 1992, Molecular endocrinology.

[150]  R. Jirtle,et al.  Modulation of insulin-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-beta 1 during liver regeneration. , 1991, The Journal of biological chemistry.

[151]  S. Thorgeirsson,et al.  Expression of transforming growth factor-beta 1 during chemical hepatocarcinogenesis in the rat. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[152]  S. Thorgeirsson,et al.  Development of resistance to the growth inhibitory effects of transforming growth factor beta 1 during the spontaneous transformation of rat liver epithelial cells. , 1991, Cancer research.

[153]  S. Kawata,et al.  Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma. , 1991, Cancer research.

[154]  A. Roberts,et al.  Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta. , 1991, Cell regulation.

[155]  H. Fujiwara,et al.  Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. , 1991, Journal of immunology.

[156]  H. Broxmeyer,et al.  Anti‐tumor effects of recombinant human macrophage colony‐stimulating factor, alone or in combination with local irradiation, in mice inoculated with lewis lung carcinoma cells , 1991, International journal of cancer.

[157]  Anita B. Roberts,et al.  Peptide Growth Factors and Their Receptors I , 1990, Springer Study Edition.

[158]  R. Jirtle,et al.  Erratum: Modulation of insulin-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-β1 during liver regeneration (Biological Chemistry, Vol. 266 (1991), 22444-22450) , 1991 .

[159]  N. Kyprianou,et al.  Effect of Transforming Growth Factor-β1 on Proliferation and Death of Rat Prostatic Cells* , 1990 .

[160]  Harold L. Moses,et al.  TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.

[161]  S. Thorgeirsson,et al.  Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. , 1990, The Journal of clinical investigation.

[162]  H. Koeppen,et al.  A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[163]  London P. Cuatrecasas.  Peptide Growth Factors and Their Receptors I , 1990, Handbook of Experimental Pharmacology.

[164]  N. Kyprianou,et al.  Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death , 1989 .

[165]  M. Czaja,et al.  In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis , 1989, The Journal of cell biology.

[166]  N. Kyprianou,et al.  Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens. , 1988, Endocrinology.